SALTS AND POLYMORPHIC FORMS OF REVUMENIB
ID202605965APending Publication Date: 2026-07-17SYNDAX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- IDP00202605797
- Authority / Receiving Office
- ID · ID
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-07-23
- Filing Date
- 2024-11-04
- Publication Date
- 2026-07-17
Abstract
This disclosure relates to new salts and salt forms of Compound A. (Compound A) This disclosure also refers to pharmaceutical compositions containing salt forms or citrate salts of Compound A and to the therapeutic use of such salts, salt forms, and compositions.
Need to check novelty before this filing date? Find Prior Art